{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-025336","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.380525+00:00","generated_at":"2026-06-28T12:47:22.357267+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Puma Biotechnology enters into $50M at-the-market equity distribution agreement with Jefferies","bullets":["Up to $50M of common stock may be sold from time to time in ATM offerings through Jefferies LLC.","Jefferies receives 3% commission on gross proceeds; sales at prevailing market prices.","Company has no obligation to sell any shares under the agreement.","Shares offered under existing shelf registration statement (File No. 333-257687) effective July 13, 2021.","Agreement may remain effective until July 2024 unless earlier terminated."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-025336","json":"https://secwatch.observer/filing/0001437749-21-025336.json","markdown":"https://secwatch.observer/filing/0001437749-21-025336.md","text":"https://secwatch.observer/filing/0001437749-21-025336.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774921025336/0001437749-21-025336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774921025336/pbyi20211104_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:47:22.357267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}